Eloxatin Concentrate for Soln for Inf 5mg/ml (20ml vial) Málta - angol - Medicines Authority

eloxatin concentrate for soln for inf 5mg/ml (20ml vial)

sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents

Eloxatin Concentrate for Soln for Inf 5mg/ml (40ml vial) Málta - angol - Medicines Authority

eloxatin concentrate for soln for inf 5mg/ml (40ml vial)

sanofi malta limited level2, fort business centre, mriehel bypass, birkirkara, malta - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents

Oxaliplatin Ebewe - (100mg vial) Pdr for Soln for Infusion 5mg/ml Málta - angol - Medicines Authority

oxaliplatin ebewe - (100mg vial) pdr for soln for infusion 5mg/ml

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - oxaliplatin - powder for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents

Oxaliplatin Ebewe - (150mg vial) Pdr for Soln for Infusion 5mg/ml Málta - angol - Medicines Authority

oxaliplatin ebewe - (150mg vial) pdr for soln for infusion 5mg/ml

1 a pharma gmbh keltenring 1+3, 82041 oberhaching, germany - oxaliplatin - powder for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents

Oxaliplatin Mylan 5mg/ml concentrate for solution for infusion Málta - angol - Medicines Authority

oxaliplatin mylan 5mg/ml concentrate for solution for infusion

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - oxaliplatin - concentrate for solution for infusion - oxaliplatin 5 mg/ml - antineoplastic agents

Methotrexate Mylan Solution for Inj/Inf 25mg/ml (2ml vial) Málta - angol - Medicines Authority

methotrexate mylan solution for inj/inf 25mg/ml (2ml vial)

mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - methotrexate - solution for infusion or injection - methotrexate 25 mg/ml - antineoplastic agents

Cisplatin 1 mg/ml Concentrate for Solution for Infusion Írország - angol - HPRA (Health Products Regulatory Authority)

cisplatin 1 mg/ml concentrate for solution for infusion

pfizer healthcare ireland - cisplatin - concentrate for solution for infusion - 1 milligram(s)/millilitre - platinum compounds; cisplatin

Cisplatin 1mg/ml Concentrate for Solution for Infusion Írország - angol - HPRA (Health Products Regulatory Authority)

cisplatin 1mg/ml concentrate for solution for infusion

accord healthcare ireland ltd. - cisplatin - concentrate for solution for infusion - 1 milligram(s)/millilitre - platinum compounds; cisplatin

Cisplatin 1 mg/ml concentrate for solution for infusion Írország - angol - HPRA (Health Products Regulatory Authority)

cisplatin 1 mg/ml concentrate for solution for infusion

fresenius kabi deutschland gmbh - cisplatin - concentrate for solution for infusion - 1 milligram(s)/millilitre - platinum compounds; cisplatin

CISPLATIN INTAS cisplatin 100 mg/100 mL concentrated injection vial Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

cisplatin intas cisplatin 100 mg/100 ml concentrated injection vial

accord healthcare pty ltd - cisplatin, quantity: 1 mg/ml - injection, concentrated - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - cisplatin intas may be used as a monotherapy or in combination with other chemotherapeutic agents in the treatment of:,? metastatic non-seminomatous germ cell carcinoma,? advanced stage, refractory ovarian carcinoma,? advanced stage, refractory bladder carcinoma,? refractory squamous cell carcinoma of the head and neck